Q2 2023 13F Holders as of 6/30/2023
-
Type / Class
-
Equity / Common stock, par value $0.001 per share
-
Shares outstanding
-
38M
-
Number of holders
-
140
-
Total 13F shares, excl. options
-
34.5M
-
Shares change
-
-1.42M
-
Total reported value, excl. options
-
$457M
-
Value change
-
-$19.2M
-
Put/Call ratio
-
0.79
-
Number of buys
-
70
-
Number of sells
-
-71
-
Price
-
$13.24
Significant Holders of ITeos Therapeutics, Inc. - Common stock, par value $0.001 per share (ITOS) as of Q2 2023
170 filings reported holding ITOS - ITeos Therapeutics, Inc. - Common stock, par value $0.001 per share as of Q2 2023.
ITeos Therapeutics, Inc. - Common stock, par value $0.001 per share (ITOS) has 140 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 34.5M shares
of 38M outstanding shares and own 90.96% of the company stock.
Largest 10 shareholders include BlackRock Inc. (4.68M shares), RA CAPITAL MANAGEMENT, L.P. (4.42M shares), MPM ASSET MANAGEMENT LLC (2.74M shares), Boxer Capital, LLC (2.15M shares), BVF INC/IL (1.81M shares), VANGUARD GROUP INC (1.77M shares), BIOIMPACT CAPITAL LLC (1.75M shares), STATE STREET CORP (1.57M shares), CITADEL ADVISORS LLC (1.2M shares), and MILLENNIUM MANAGEMENT LLC (826K shares).
This table shows the top 140 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.